Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record.

Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial

Open access

Abstract

Objective: Most fear of cancer recurrence (FCR) interventions have small effects, and few target FCR. This randomized controlled trial (RCT) with breast and gynecological cancer survivors evaluated the efficacy of a cognitive-existential fear of recurrence therapy (FORT) compared to an attention placebo control group (living well with cancer [LWWC]) on FCR. Method: One hundred and sixty-four women with clinical levels of FCR and cancer distress were randomly assigned to 6-weekly, 120 min FORT (n= 80) or LWWC (n= 84) group sessions. They completed questionnaires at baseline (T1), posttreatment (T2; primary endpoint), 3 (T3), and 6 months (T4) posttreatment. Generalized linear models were used to compare group differences in the fear of cancer recurrence inventory (FCRI) total score and secondary outcomes. Results: FORT participants experienced greater reductions from T1 to T2 on FCRI total with a between-group difference of−9.48 points ( p=.0393), resulting in a medium effect of−0.530, with a maintained effect at T3 ( p=.0330) but not at T4. For the secondary outcomes, improvements were in favor of FORT, including FCRI triggers ( p=.0208), FCRI coping ( p=.0351), cognitive avoidance ( p=.0155), need for reassurance from physicians ( p=.0117), and quality of life (mental health; p=.0147). Conclusions: This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecological cancer, indicating its potential as a new treatment strategy. We recommend a booster session to sustain gains © 2023 American Psychological Association

Overview

Integrity signals

Registry

Crossref · 10.1037/hea0001253

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

See all 44

Metadata

Authors
Maheu, C., Lebel, S., Bernstein, L. J., Courbasson, C., Singh, M., Ferguson, S. E., Harris, C., Jolicoeur, L., Baku, L., Muraca, L., Ramanakumar, A. V., Lamonde, F., Lefebvre, M., Tomei, C., Mutsaers, B., Secord, S., Power, J., Drummond, N., Hébert, M., & Wani, R. J.
Affiliations
  • McGill University (CA)
  • University of Ottawa (CA)
  • University Health Network (CA)
  • York University (CA)
  • Ottawa Hospital (CA)
  • University of Waterloo (CA)
  • Mount Sinai Hospital (CA)
  • McGill University Health Centre (CA)
  • Jewish General Hospital (CA)
  • Université du Québec à Trois-Rivières (CA)
Venue
Health Psychology
Published
2023-03
Volume
42
Issue
3
Pages
182-194
ISSN
  • 0278-6133 (ISSN-L)
  • 1930-7810
OpenAlex
W4322757424
Cited by
43
References
0
Citations by year
2026: 15 · 2025: 19 · 2024: 5 · 2023: 4
FWCI
5.44
Type
journal article
Language
en
Open access
Locations
  • Health Psychology (publishedVersion, other-oa)
  • PubMed (publishedVersion)
Funders
  • Réseau de recherche en interventions en sciences infirmières du Québec/Quebec Network on Nursing Interventions Research
  • McGill University
  • Canadian Cancer Society Research Institute (702589)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
fear of cancer recurrence, breast cancer survivors, gynecologic cancer survivors, cancer-related distress, coping, cognitive avoidance, reassurance seeking, quality of life, booster sessions, psycho-oncology
MeSH terms
Cancer Survivors, Adaptation, Psychological, Fear, Female, Humans, Neoplasms, Phobic Disorders, Recurrence, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1037/hea0001253
The paper
Maheu, C., Lebel, S., Bernstein, L. J., Courbasson, C., Singh, M., Ferguson, S. E., Harris, C., Jolicoeur, L., Baku, L., Muraca, L., Ramanakumar, A. V., Lamonde, F., Lefebvre, M., Tomei, C., Mutsaers, B., Secord, S., Power, J., Drummond, N., Hébert, M., & Wani, R. J. (2023). Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial. Health Psychology. https://doi.org/10.1037/hea0001253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.